HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modeling amantadine treatment of influenza A virus in vitro.

Abstract
We analyzed the dynamics of an influenza A/Albany/1/98 (H3N2) viral infection, using a set of mathematical models highlighting the differences between in vivo and in vitro infection. For example, we found that including virion loss due to cell entry was critical for the in vitro model but not for the in vivo model. Experiments were performed on influenza virus-infected MDCK cells in vitro inside a hollow-fiber (HF) system, which was used to continuously deliver the drug amantadine. The HF system captures the dynamics of an influenza infection, and is a controlled environment for producing experimental data which lend themselves well to mathematical modeling. The parameter estimates obtained from fitting our mathematical models to the HF experimental data are consistent with those obtained earlier for a primary infection in a human model. We found that influenza A/Albany/1/98 (H3N2) virions under normal experimental conditions at 37 degrees C rapidly lose infectivity with a half-life of approximately 6.6+/-0.2 h, and that the lifespan of productively infected MDCK cells is approximately 13 h. Finally, using our models we estimated that the maximum efficacy of amantadine in blocking viral infection is approximately 74%, and showed that this low maximum efficacy is likely due to the rapid development of drug resistance.
AuthorsCatherine A A Beauchemin, James J McSharry, George L Drusano, Jack T Nguyen, Gregory T Went, Ruy M Ribeiro, Alan S Perelson
JournalJournal of theoretical biology (J Theor Biol) Vol. 254 Issue 2 Pg. 439-51 (Sep 21 2008) ISSN: 1095-8541 [Electronic] England
PMID18653201 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Amantadine
Topics
  • Amantadine (therapeutic use)
  • Animals
  • Cell Death
  • Cell Line
  • Dogs
  • Drug Resistance, Viral
  • Influenza A Virus, H3N2 Subtype
  • Influenza A Virus, H5N1 Subtype
  • Influenza A virus
  • Kidney (virology)
  • Models, Biological
  • Orthomyxoviridae Infections (drug therapy, virology)
  • Time Factors
  • Virion
  • Virology (instrumentation, methods)
  • Virulence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: